169 related articles for article (PubMed ID: 12170732)
1. [Contribution of Japanese researchers to progress in the field of pulmonary medicine in the last 100 years: New pharmacological action of macrolides].
Sugiyama Y
Nihon Naika Gakkai Zasshi; 2002 Jun; 91(6):1716-8. PubMed ID: 12170732
[No Abstract] [Full Text] [Related]
2. The newer macrolides. Azithromycin and clarithromycin.
Zuckerman JM; Kaye KM
Infect Dis Clin North Am; 1995 Sep; 9(3):731-45. PubMed ID: 7490441
[TBL] [Abstract][Full Text] [Related]
3. Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan.
Shimizu T; Suzaki H
Auris Nasus Larynx; 2016 Apr; 43(2):131-6. PubMed ID: 26441370
[TBL] [Abstract][Full Text] [Related]
4. [New therapeutic uses of the macrolides].
Mihălţan F
Pneumologia; 2004; 53(3):100-4. PubMed ID: 16108157
[No Abstract] [Full Text] [Related]
5. Clinical implications of macrolide resistance in community-acquired respiratory tract infections.
Hoban DJ; Zhanel GG
Expert Rev Anti Infect Ther; 2006 Dec; 4(6):973-80. PubMed ID: 17181414
[TBL] [Abstract][Full Text] [Related]
6. [Effects of azithromycin on the virulence of Pseudomonas aeruginosa].
Reinert P
Pathol Biol (Paris); 1995 Jun; 43(6):551-3. PubMed ID: 8539081
[TBL] [Abstract][Full Text] [Related]
7. [Progress in the field of pulmonary medicine in the last 100 years: Medical history of diffuse panbronchiolitis].
Kudo S
Nihon Naika Gakkai Zasshi; 2002 Jun; 91(6):1786-9. PubMed ID: 12170746
[No Abstract] [Full Text] [Related]
8. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
Amsden GW
J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
[TBL] [Abstract][Full Text] [Related]
9. Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion.
Aktan B; Taysi S; Gümüştekin K; Uçüncü H; Memişoğullari R; Save K; Bakan N
Pol J Pharmacol; 2003; 55(6):1105-10. PubMed ID: 14730107
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of bacterial resistance to macrolides.
Halpern MT; Schmier JK; Snyder LM; Asche C; Sarocco PW; Lavin B; Nieman R; Mandell LA
J Antimicrob Chemother; 2005 May; 55(5):748-57. PubMed ID: 15772147
[TBL] [Abstract][Full Text] [Related]
11. Erythromycin, clarithromycin, and azithromycin: are the differences real?
Amsden GW
Clin Ther; 1996; 18(1):56-72; discussion 55. PubMed ID: 8851453
[TBL] [Abstract][Full Text] [Related]
12. Use of flurythromycin ethylsuccinate in infections of lower airways due to sensitive germs: multicenter comparative study with clarithromycin.
Vagliasindi M
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):245-9. PubMed ID: 9208340
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic interaction study between midazolam and the macrolide antibiotics, erythromycin, clarithromycin, and the azalide azithromycin.
Yeates RA; Laufen H; Zimmermann T; Schumacher T
Int J Clin Pharmacol Ther; 1997 Dec; 35(12):577-9. PubMed ID: 9455717
[TBL] [Abstract][Full Text] [Related]
14. The new macrolides. Azithromycin and clarithromycin.
Kanatani MS; Guglielmo BJ
West J Med; 1994 Jan; 160(1):31-7. PubMed ID: 8128699
[TBL] [Abstract][Full Text] [Related]
15. [Clinical application of the new action of macrolide preparations to respiratory diseases].
Mikasa K; Furunishi M; Maeda K; Sakamoto M; Ueta K; Mashima T; Kita E; Narita N
Nihon Naika Gakkai Zasshi; 1999 Aug; 88(8):1533-40. PubMed ID: 10475020
[No Abstract] [Full Text] [Related]
16. New erythromycins.
Wynn RL
Gen Dent; 1996; 44(4):304-7. PubMed ID: 8957824
[No Abstract] [Full Text] [Related]
17. Comparison of four antibiotics in a murine model of necrotizing cutaneous infections caused by toxigenic Streptococcus pyogenes and Staphylococcus aureus.
Barg N
J Antimicrob Chemother; 1998 Aug; 42(2):257-60. PubMed ID: 9738847
[TBL] [Abstract][Full Text] [Related]
18. [Macrolide antibiotics. Fast development of resistant streptococci].
Martini B
Med Monatsschr Pharm; 2008 Apr; 31(4):156. PubMed ID: 18497255
[No Abstract] [Full Text] [Related]
19. Macrolides in dermatology.
Scheinfeld NS; Tutrone WD; Torres O; Weinberg JM
Dis Mon; 2004 Jul; 50(7):350-68. PubMed ID: 15280867
[No Abstract] [Full Text] [Related]
20. Antibiotic-induced apoptosis in human activated peripheral lymphocytes.
Kadota J; Mizunoe S; Kishi K; Tokimatsu I; Nagai H; Nasu M
Int J Antimicrob Agents; 2005 Mar; 25(3):216-20. PubMed ID: 15737515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
